Cite
Inhibition of abnormal C/EBPβ/α‐Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease‐like pathology.
MLA
Lin, Zefang, et al. “Inhibition of Abnormal C/EBPβ/Α‐Syn Signaling Pathway through Activation of Nrf2 Ameliorates Parkinson’s Disease‐like Pathology.” Aging Cell, vol. 22, no. 10, Oct. 2023, pp. 1–17. EBSCOhost, https://doi.org/10.1111/acel.13958.
APA
Lin, Z., Huang, L., Cao, Q., Luo, H., Yao, W., & Zhang, J. (2023). Inhibition of abnormal C/EBPβ/α‐Syn signaling pathway through activation of Nrf2 ameliorates Parkinson’s disease‐like pathology. Aging Cell, 22(10), 1–17. https://doi.org/10.1111/acel.13958
Chicago
Lin, Zefang, Lixuan Huang, Qianqian Cao, Hanyue Luo, Wei Yao, and Ji‐chun Zhang. 2023. “Inhibition of Abnormal C/EBPβ/Α‐Syn Signaling Pathway through Activation of Nrf2 Ameliorates Parkinson’s Disease‐like Pathology.” Aging Cell 22 (10): 1–17. doi:10.1111/acel.13958.